Kanker Payudara

Strengthening Health Diplomacy: WHO Director-General Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan strengthening-health-diplomacy-who-director-general-dr-tedros-adhanom-ghebreyesus-concludes-landmark-visit-to-jordan

Strengthening Health Diplomacy: WHO Director-General Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan

Rifan Muazin October 13, 2026

AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded a pivotal...

Redefining the Horizon: How Innovation and Equity are Transforming Metastatic Breast Cancer Care in Canada redefining-the-horizon-how-innovation-and-equity-are-transforming-metastatic-breast-cancer-care-in-canada

Redefining the Horizon: How Innovation and Equity are Transforming Metastatic Breast Cancer Care in Canada

Asro October 13, 2026

Metastatic breast cancer (mBC)—clinically identified as Stage IV—represents the most complex frontier in oncology. When cancer cells...

Breakthrough Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-research-reveals-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth

Breakthrough Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Lina Hope October 13, 2026

NORMAN, OK – In a significant advancement for cancer research, scientists at the University of Oklahoma (OU)...

Breakthrough in Schizophrenia Treatment: Obuprazine Shows Significant Efficacy in Phase IIb Trial breakthrough-in-schizophrenia-treatment-obuprazine-shows-significant-efficacy-in-phase-iib-trial

Breakthrough in Schizophrenia Treatment: Obuprazine Shows Significant Efficacy in Phase IIb Trial

Layla Zulfa October 13, 2026

New Drug Candidate Demonstrates Robust Clinical Improvement in Acute Schizophrenia Patients, Outperforming Standard of Care in Key...

Navigating the Nuances: GLP-1 Medications and Their Emerging Relationship with Breast Cancer navigating-the-nuances-glp-1-medications-and-their-emerging-relationship-with-breast-cancer

Navigating the Nuances: GLP-1 Medications and Their Emerging Relationship with Breast Cancer

Asro October 13, 2026

By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists have surged...

Breakthrough in Celiac Research: First Tracks’ ANB033 Shows “Pipeline-in-a-Product” Potential breakthrough-in-celiac-research-first-tracks-anb033-shows-pipeline-in-a-product-potential-1

Breakthrough in Celiac Research: First Tracks’ ANB033 Shows “Pipeline-in-a-Product” Potential

Neng Nana October 13, 2026

By Delilah Alvarado Published October 12, 2026 In a significant development for the treatment of autoimmune disorders,...

Navigating the Frontier: The FDA’s New Regulatory Blueprint for Generative AI in MedTech navigating-the-frontier-the-fdas-new-regulatory-blueprint-for-generative-ai-in-medtech

Navigating the Frontier: The FDA’s New Regulatory Blueprint for Generative AI in MedTech

Asro October 13, 2026

The integration of artificial intelligence (AI) into medical technology has moved beyond the realm of speculative innovation...

Unlocking the Cellular Architecture of Age-Related Hearing Loss: An Interview with Dr. Samah Ahmed unlocking-the-cellular-architecture-of-age-related-hearing-loss-an-interview-with-dr-samah-ahmed-1

Unlocking the Cellular Architecture of Age-Related Hearing Loss: An Interview with Dr. Samah Ahmed

Asro October 13, 2026

Age-related hearing loss, often dismissed as an inevitable consequence of the human aging process, is undergoing a...

The Silent Power: Why Yoga Practitioners Are Winning the Modern Endurance Challenge the-silent-power-why-yoga-practitioners-are-winning-the-modern-endurance-challenge

The Silent Power: Why Yoga Practitioners Are Winning the Modern Endurance Challenge

Raul Delapena Setiawan October 13, 2026

Published October 12, 2026 In an era defined by high-intensity interval training (HIIT) and the pursuit of...

The Resilience of Pride: Richard Goldman’s Lifelong Journey of Advocacy and Service the-resilience-of-pride-richard-goldmans-lifelong-journey-of-advocacy-and-service

The Resilience of Pride: Richard Goldman’s Lifelong Journey of Advocacy and Service

Muslim October 13, 2026

Introduction: A Legacy of Compassion In the tapestry of the LGBTQ+ rights movement, the true strength of...

Strengthening Health Diplomacy: WHO Director-General Dr. Tedros Adhanom Ghebreyesus Concludes Landmark Visit to Jordan

Redefining the Horizon: How Innovation and Equity are Transforming Metastatic Breast Cancer Care in Canada

Breakthrough Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Breakthrough in Schizophrenia Treatment: Obuprazine Shows Significant Efficacy in Phase IIb Trial

Navigating the Nuances: GLP-1 Medications and Their Emerging Relationship with Breast Cancer

Breakthrough in Celiac Research: First Tracks’ ANB033 Shows “Pipeline-in-a-Product” Potential

Navigating the Frontier: The FDA’s New Regulatory Blueprint for Generative AI in MedTech

The Silent Power: Why Yoga Practitioners Are Winning the Modern Endurance Challenge

The Resilience of Pride: Richard Goldman’s Lifelong Journey of Advocacy and Service

You may have missed

Unveiling a Cancer’s Deceptive Alliance: OU Research Exposes How Breast Tumors Recruit Nerves to Fuel Growth

Influenza mortality in hospitalised patients affected by vaccination

Beyond the Pink: Demanding Transparency and Tangible Impact in Breast Cancer Awareness Month Campaigns

The Stage IV Stampede: Metastatic Breast Cancer Advocates Descend on Capitol Hill to Demand Legislative Reform